Shawn K. Singh

2020

In 2020, Shawn K. Singh earned a total compensation of $933.7K as Chief Executive Officer at Vistagen Therapeutics, a 2% decrease compared to previous year.

Compensation breakdown

Option Awards$435,667
Salary$498,000
Total$933,667

Singh received $498K in salary, accounting for 53% of the total pay in 2020.

Singh also received $435.7K in option awards.

Rankings

In 2020, Shawn K. Singh's compensation ranked 8,916th out of 13,090 executives tracked by ExecPay. In other words, Singh earned more than 31.9% of executives.

ClassificationRankingPercentile
All
8,916
out of 13,090
32nd
Division
Manufacturing
3,811
out of 5,621
32nd
Major group
Chemicals And Allied Products
1,543
out of 2,254
32nd
Industry group
Drugs
1,346
out of 1,954
31st
Industry
Pharmaceutical Preparations
996
out of 1,459
32nd
Source: SEC filing on July 27, 2020.

Singh's colleagues

We found four more compensation records of executives who worked with Shawn K. Singh at Vistagen Therapeutics in 2020.

2020

H Snodgrass

Vistagen Therapeutics

Chief Scientific Officer

2020

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

2020

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

2020

Mark McPartland

Vistagen Therapeutics

Vice President, Corporate Development

News

You may also like